0% found this document useful (0 votes)
2 views6 pages

AACA_Factsheet_Mar2025

The market outlook for June 2024 indicates a continued decline in Indian equities, with the Nifty index down 5.9% in February 2025, reflecting widespread pessimism across sectors. Key developments include a 25-bps cut in the repo rate by the RBI and a focus on fiscal consolidation in the Union Budget, while Foreign Portfolio Investors sold $4.7 billion in equities. Despite challenges, the portfolio strategy remains focused on fundamental investing, with a long-term view of potential market recovery.

Uploaded by

anubhabsahoo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
2 views6 pages

AACA_Factsheet_Mar2025

The market outlook for June 2024 indicates a continued decline in Indian equities, with the Nifty index down 5.9% in February 2025, reflecting widespread pessimism across sectors. Key developments include a 25-bps cut in the repo rate by the RBI and a focus on fiscal consolidation in the Union Budget, while Foreign Portfolio Investors sold $4.7 billion in equities. Despite challenges, the portfolio strategy remains focused on fundamental investing, with a long-term view of potential market recovery.

Uploaded by

anubhabsahoo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

June

June 2024
2022

Monthly
Communication
March 2025

www.abakkusinvest.com

STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com
STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com
Market Outlook June 2024
March 2025

Market Update yield ended February at 6.7%, while the USD/INR exchange rate
was 87.40. Brent crude oil prices also rose, closing at around $73
Indian equities registered its fifth consecutive monthly loss per barrel in February.
In February 2025. Sentiment was visibly pessimistic, and Gross GST collections were ₹1.84 lakh crore in February 2025,
losses were widespread. While Nifty index continued decline reflecting a 9.1% rise compared to February 2024, and 9.4%
by 5.9% for the month, the broader markets saw sharper increase year-to-date.
declines with the midcap and small cap indices down 10.8%
and 13.1% respectively. All the sectors ended the month in Brent Crude
red; with Capital Goods, PSU and Real estate falling the most
130
by 14.4%, 13.5% and 13.4%, respectively.
120

Key domestic developments included the Union Budget 110

which saw continued government’s focus on fiscal 100

consolidation while providing a boost to consumption by 90

way of tax cuts. The RBI started off the rate-cut cycle with a 80

25-bps cut in repo rate to 6.25%, after being on a pause for 70 73

24 months. It also reduced risk weights for bank financing to 60

NBFCs and microfinance loans. BJP won the Delhi legislative

Nov-22

Nov-23

Jan-24

Nov-24
May-22
Jun-22
Jul-22
Aug-22
Sep-22

Jan-23
Feb-23

Jun-23
Jul-23
Aug-23

Jan-25
May-23

Sep-23

Feb-24

May-24
Jun-24

Feb-25
Dec-22

Mar-23
Oct-22

Oct-23

Dec-23

Mar-24

Jul-24
Aug-24
Sep-24
Oct-24

Dec-24
Apr-22

Apr-23

Apr-24
assembly elections with 48 out of 70 seats, marking its return
to power in the capital after 27 years. Source: Bloomberg

On the investment front, Foreign Portfolio Investors (FPIs) sold Earnings Review – 3QFY25
$4.7 billion of Indian equities in secondary market by February The 3QFY25 corporate earnings season was modest, with
27. Domestic Institutional Investors (DIIs) were net buyers, BFSI, Technology, Telecom, Healthcare, Capital Goods, and
acquiring $6 billion worth of stocks by the end of the month. Real Estate contributing positively. Nifty delivered a 5%
Meanwhile, global markets saw mixed results: Indonesia YoY PAT growth, marking the third successive quarter of
recorded a significant loss of (-11.8%), while Thailand (-8.4%) single-digit growth since the pandemic. This growth was
and Japan (-6.1%) also experienced declines. On the positive significantly supported by a few key players, while others
side, markets in Hong Kong (+13.4%), Germany (+3.8%), and negatively impacted the overall performance. The earnings
Mexico (+3.0%) saw gains. growth was hindered by sectors such as O&G (OMC’s profit
declined 18% YoY), Cement (-55% YoY), Chemicals (-12%
Global and regional indices 1 Month performance (%)
YoY), and Consumer (-5% YoY).
A concerning trend emerged as earnings downgrades
15 13.4
outnumbered upgrades, particularly outside the Nifty 50
10 universe. While the EBITDA margin (excluding Financials)
5 3.8 3 2.3 2.2 2.0 2.0 expanded slightly, the gross margin contracted for most
1.6 1.1 1 0.6
sectors. Overall, the 3QFY25 earnings aligned with modest
0
expectations, but the forward earnings revisions are the
-2 -2.7 -2.9
-5
-4.2 weakest in recent times, indicating forecasts of potential
-5.9 -6.1
-10 -8.4 pressure on future earnings, especially for mid and small-
-15 -11.8 cap companies.
UK
Hong Kong
Germany

France

Singapore
Malaysia

US S&P 500

Australia
Korea

Indonesia
Nifty 50
Philippines

US Dow Jones
Mexico

Taiwan

Japan
Thailand
Shanghai

Brazil

Nifty sales up 6% YoY in 3QFY25


Source: Bloomberg, Kotak Institutional Equities (Data as on 28th February 2025 in local
currency)

Macro Update
In February, the National Statistics Office (NSO) estimated
India’s FY25 real GDP growth at 6.5% revising upward from 6.4%
as estimated in Jan’25. Inflationary pressures continued easing,
with the Consumer Price Index (CPI) falling to 4.3% in January
2025 from 5.2% in December, the lowest YoY inflation since Aug’24.
The Wholesale Price Index (WPI) also fell to 2.3% in January YoY,
from 2.4% in the previous month. Industrial production registered
a 3.2% growth in December, in comparison to 5.2% growth in
November.
India’s exports grew by 7.2% during the April-January 24-25
period compared to the same months in 23-24, while imports
Source: Motilal Oswal Financial Services Limited
rose by 9%, leading to a trade deficit of $87.5 billion for the first
ten months of FY2025. The country’s 10-year government bond

STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com
June 2024
March 2025

Nifty EBITDA up 8% YoY in 3QFY25 Nifty PAT up 5% YoY

Source: Motilal Oswal Financial Services Limited

change and should bring in new thoughts.


Market Outlook Globally, the Trump rhetoric now looks a bit too stretched.
The nervousness in the markets continued in February, The US $ index has already dropped to below 104 from a
with the broader markets seeing further price fall. Earnings recent high of 110 and most experts have now started calling
for the quarter, though slightly better than the previous that the US $ has seen its recent highs and should be weaker
quarter, continued to be lower than long-term trends and going forward. The tariff announcements have become too
expectations. The Trump era uncertainty and daily news regular with constant back and fro and should now have
flows continued causing almost daily uncertainty and lesser effect on the markets generally.
volatility. FII selling also continued unabated adding to the Our view is that both news flow as well as domestic macro
pressure on the markets. Though domestic funds continued and corporate data should be incrementally positive.
to be large buyers of Indian equities, unwinding from However, despite the sharp fall, Indian stocks generally are
individual investors was widespread. not cheap. However, there are pockets of good opportunities
In India, we have seen changes in leadership in two key emerging and our attempt will be to focus on that segment.
regulators. The central bank, RBI, has already seen a change We continue to have a view of a slow uptick in the markets
of stance and has pumped in quite a bit of liquidity in the with intermittent swings. Portfolio damage over the last two
economy, including a rate cut after almost three years. This months has been meaningful, but our fundamental focus
should start to show its effect on the economy in coming gives us confidence of a sharper bounce back as and when
months. SEBI, the capital market regulator, has also seen a the markets stabilize.

STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com
Abakkus All Cap Approach
PMS Strategy June 2024
March 2025

Portfolio Update
The Portfolio continues to focus on our core philosophy of fundamental based investing. The portfolio, in a challenging
month, saw a meaningful drawdown, though inline and lower than the broader markets (midcap and small cap
indices down 10.8% and 13.1% respectively). Since inception the portfolio is up 150.0% absolute. Stock price and market
movements have been more on news flows and that has caused near-term performance movements. We believe
our focus on risk-adjusted returns will enable us to tide over these near-term challenges and generate decent returns
and alpha for our investors.

Portfolio Performance as on February 28, 2025 (in INR)

Since
1 3 6 1 2 3 Since FY25
Inception FY24 CY25 CY24
Period Month Months Months Year Years Years Inception YTD
Absolute (%) YTD(%) (%)
(%) (%) (%) (%) (%) (%) CAGR (%) (%)
(%)

Abakkus All
-8.4 -15.1 -17.9 -7.2 17.3 12.4 23.5 150.0 -5.7 44.8 -13.9 13.5
Cap Approach

BSE 500 TRI -7.7 -12.2 -16.1 -0.4 17.8 12.7 19.4 116.5 -1.3 40.2 -10.9 15.8
**Unaudited Performance data for Portfolio Manager and Investment Approach provided hereunder is not verified by any regulatory authority and Past performance may
or may not sustain in the future. The performance is based on TWRR as on February 28, 2025. Inception Date is October 29, 2020. As per SEBI guidelines, returns are net of all
expenses and investor returns may differ, based on their period of investment, fee structure and point of capital flows.

Top 5 Sector Classification as on February 28, 2025 Top 10 Holdings on the basis of Asset %*

Sector Asset % SUN PHARMACEUTICAL INDUS- AXIS BANK LIMITED


TRIES LIMITED
BANKS 17.6
HDFC BANK LIMITED LARSEN AND TOUBRO LIMITED
INDUSTRIALS 11.3
HCL TECHNOLOGIES LIMITED STATE BANK OF INDIA
COMMODITIES 9.9
BHARTI AIRTEL PP LIMITED NTPC LIMITED
TELECOMMUNICATION 9.6
MAX FINANCIAL SERVICES JINDAL STAINLESS LIMITED
HEALTH CARE 9.2 LIMITED
Securities/sectors quoted are for illustration only and not recommendatory. The Data as on February 28, 2025. *The current portfolio holdings may or may not be
sectors are classified as per internal classification. a part of the future portfolio holdings and may or may not be part of all client
portfolios.

STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com
Disclaimers
June 2024
March 2025

About Us website/email/content are true to the best of its knowledge,


Abakkus Asset Manager Private Limited (formerly known as however, assume no liability for the relevance, accuracy or
Abakkus Asset Manager LLP) (“Abakkus”) is registered as a completeness of the contents herein.
Portfolio Manager with SEBI under SEBI (Portfolio Managers)
Regulations, 2020 as amended from time to time and the Abakkus declares that the data and analysis provided shall
Circulars and Guidelines issued there under from time to time be for informational purposes. The information contained in
vide SEBI Reg. No.: INP000006457 dated March 14, 2019 and the analysis shall been obtained from various sources and
as an Investment Advisor under SEBI (Investment Advisors) reasonable care would be taken to ensure sources of data to
Regulations, 2013 as amended from time to time and the be accurate and reliable. Abakkus will not be responsible for any
Circulars and Guidelines issued there under from time to time error or omission in the data or for any losses suffered on account
vide SEBI Reg. No.: INA000015729 dated February 03, 2021. of information contained in the analysis. While the Abakkus
will take due care to ensure that all information provided is
Abakkus is also the Investment Manager to Abakkus Growth accurate however the Abakkus neither guarantees/warrants the
Fund, a SEBI registered Category III AIF vide SEBI Reg. No.: IN/ sequence, accuracy, completeness, or timeliness of the report.
AIF3/18-19/0550 dated June 05, 2018, India-Ahead Venture Neither the Abakkus nor its affiliates or their partners, directors,
Trust, a SEBI registered Category I AIF vide SEBI Reg. No.: IN/ employees, agents, or representatives, shall be responsible or
AIF1/21-22/0976 dated January 25, 2022, India-Ahead Private liable in any manner, directly or indirectly, for views or opinions
Equity Trust, a SEBI registered Category II AIF vide SEBI Reg. No.: expressed in this analysis or the contents or any systemic errors
IN/AIF2/21-22/0980 dated January 27, 2022 and Abakkus India or discrepancies or for any decisions or actions taken in reliance
Equity Trust, a SEBI registered Category III AIF vide SEBI Reg. No.: on the analysis. Abakkus does not take any responsibility for any
IN/AIF3/23-24/1326 dated August 9, 2023 under SEBI (Alternative clerical, computational, systemic, or other errors in comparison
Investment Fund) Regulations, 2012 as amended from time analysis.
to time and the Circulars and Guidelines issued there under
from time to time collectively referred as the SEBI Registered There can be no assurance that future results, performance or
Intermediary. The branch office of Abakkus situated at IFSC-GIFT events will be consistent with the information provided in this
City is registered with the IFSCA as Registered FME (Non-retail) content and the past performance, if any is not the guarantee
(IFSCA/FME/II/2022-23/041) under IFSCA (Fund Management) of the future/assured performance. Any decision or action
Regulations, 2022. taken by the recipient/visitor of this website/email/content
based on this information shall be solely and entirely at the
Disclaimer and Disclosures risk of the recipient/visitor of the website/email/content. The
This website/email/content is confidential and is intended only distribution of this information in some jurisdictions may be
for the personal use of the prospective investors/contributors restricted and/or prohibited by law, and persons into whose
(herein after referred as the Clients) to whom it is addressed possession this information comes should inform themselves
or delivered and must not be reproduced or redistributed in about such restriction and/or prohibition and observe any such
any form to any other person without prior written consent of restrictions and/or prohibition. Unauthorized disclosure, use,
Abakkus. This website/email/content does not purport to be publication, dissemination or copying (either whole or partial) of
all-inclusive, nor does it contain all of the information which a this information, is prohibited. Abakkus shall not treat recipient/
prospective investor may desire. This website/email/content is user as a client by virtue of his receiving/using the contents of
neither approved, certified nor its contents is verified by SEBI. the document in full or part. Neither the Abakkus nor its affiliates,
directors, partners, employees, agents, or representatives, shall
Abakkus retains all the rights in relation to all information be responsible or liable in any manner, directly or indirectly, for
contained in the website/email/content(s) and to update the the contents or any errors or discrepancies herein or for any
same periodically or otherwise from time to time. The website/ decisions or actions taken in reliance on the information. The
email/content is neither a general offer nor solicitation to avail person accessing this information specifically agrees to exempt/
the service of investment from the SEBI Registered Intermediary absolve the Abakkus or any of its affiliates or employees from,
under the services offered by Abakkus/Fund nor is it an offer to any and all responsibility/liability arising from such misuse/
sell or a generally solicit an offer to become an investor in the improper/ illegal use and agrees not to hold the Abakkus or any
services offered by the Abakkus/Fund. The delivery of this email/ of its affiliates or employees responsible for any such misuse/
content at any time does not imply that information herein is improper/illegal use and further agrees to hold the Abakkus
correct as of any time subsequent to its date. The contents of or any of its affiliates or employees free and harmless from all
this website/email/content are provisional and may be subject losses, costs, damages, expenses that may be suffered by the
to change. In the preparation of the material contained in this person accessing this information due to any errors and delays.
website/email/content, Abakkus has used information that is
publicly available, certain research reports including information Abakkus (including its affiliates) and any of its Partners, officers,
developed in-house. Abakkus warrants that the contents of this employees, and other personnel will not accept any liability,

STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com
Disclaimers
June 2024
March 2025

loss, damage of any nature, including but not limited to direct, with each other.
indirect, punitive, special, exemplary, consequential, as also any
loss of profit in any way arising from the use of this website/ Abakkus operates from within India and is subject to Indian
email/content or any information in any manner whatsoever. laws and any dispute shall be resolved in the courts of Mumbai,
Maharashtra only.
This website/email/content may include certain forward-looking
words, statements and scenario which contain words or phrases Redressal of client grievances
such as “believe”, “expect”, “anticipate”, “estimate”, “intend”, Investors can seek clarification for their queries and are further
“plan”, “objective”, “goal”, “project”, “endeavour” and similar entitled to make a complaint in writing, verbally or telephonically. An
expressions or variations of such expressions that are forward- email may be sent to:
looking statements, words, and scenario. Actual results may For PMS, IA and AIF related queries and complaints - service@
differ materially from those suggested by the forward-looking abakkusinvest.com and [email protected]
statements due to risks, uncertainties, or assumptions. Abakkus (both) Alternatively, the Investor may call on +91 22 6884 6601/02/85
takes no responsibility of updating any data/information.
Alternative Investment Fund
The contents of this website/email/content cannot be copied, As per SEBI Circular No. SEBI/HO/IMD/DF6/CIR/P/2020/24 dated
reproduced, in whole or in part or otherwise distributed without February 05, 2020, details of industry benchmark and AIF level
prior written approval of the Abakkus. performance versus Benchmark Reports are available at https://
www.nseindia.com/products-services/aif-benchmark-report and
https://www.crisil.com/en/home/what-we-do/financial-products/
Prospective investors/clients are advised to review this website/
alternate-investment-funds-benchmarks.html
email/content, the Private Placement Memorandum/Disclosure
Document, the Contribution Agreement/Client Agreement,
representations and presentation(s) and other related
Compliance Officer details under AIF:
documents carefully and in its entirety and seek clarification
Mr. Biharilal Deora, Tel: 022-68846600
wherever required from the SEBI Registered Intermediary/
Abakkus. Prospective investors should make an independent
Portfolio Management Services:
assessment, and consult their own counsel, business advisor
You may refer the Disclosure Document available at https://
and tax advisor as to legal, business and tax related matters
abakkusinvest.com/investor/disclosures for detailed
concerning this document and the other related documents
disclosures. As per SEBI circular SEBI/HO/IMD/IMD-PoD-2/P/
before becoming investing with/though the Abakkus/in the
CIR/2022/172 dated December 16, 2022, the comparison of the
Fund.
relative performance of the investment approach with other
portfolio managers is available at https://www.apmiindia.org/
The information contained in this website/email/content has been
apmi/IACompare.htm?action=iacomaprepage
prepared for general guidance and does not constitute a professional
advice/assurance and no person should act upon any information
Principal Officer and Compliance Officer Details under PMS:
contained herein without obtaining specific professional advice/
Principal Officer: Mr. Aman Chowhan, Tel: 022-68846600
Assurance. Neither the Abakkus nor its Affiliates or advisors would
Compliance Officer: Mr. Biharilal Deora, Tel: 022-68846600
be held responsible for any reliance placed on the content of this
document or for any decision based on it. Each existing/prospective
Investment Advisory Services:
client, by accepting delivery of this document agrees to the foregoing.
You may refer the Disclosure Document available at
The Investment portfolio are subject to several risk factors including
https://abakkusinvest.com/investor/disclosures
but not limited to political, legal, social, economic, and overall market
risks. The recipient alone shall be fully responsible/are liable for any
Principal Officer and Compliance Officer Details under IA:
decision taken on the basis of this document. Abakkus, its partners,
Principal Officer: Mr. Biharilal Deora, Tel: 022-68846600
employees, PMS clients, AIF scheme(s), Advisory clients may have
Compliance Officer: Mr. Lijo Varghese, Tel: 022-68846600
existing exposure to the stocks that form part of the PMS portfolio/
Advisory portfolio/AIF scheme(s). Further, in view of the investment
Contact Us:
objective/strategy of the PMS /Advisory and AIF scheme(s) there
Website: www.abakkusinvest.com
may be situations where Abakkus may be selling a stock which is
Email: [email protected]
part of the PMS portfolio/Advisory portfolio/AIF scheme as the case
Tel: 022-68846600
may be.

Corporate and Registered Address:


Abakkus (including its affiliates) may offer services in nature of
Abakkus Corporate Center, 6th Floor, Param House, Shanti Nagar,
advisory, consultancy, portfolio management, sponsorship of
Near Grand Hyatt, Off Santacruz Chembur Link Road, Santacruz
funds, investment management of funds which may conflict
East, Mumbai – 400055. CIN: U70200MH2024PTC432609
STRICTLY CONFIDENTIAL. FOR PRIVATE CIRCULATION ONLY, NOT FOR PUBLIC DISTRIBUTION www.abakkusinvest.com

You might also like